Fever, pancytopenia, and splenomegaly 8 months after a trip to Majorca Island (Spain);Hohes fieber, panzytopenie und splenomegalie 8 monate nach einem Mallorca-Urlaub

Medizinische Klinik

Volumn 103, Issue 1, 2008, Pages 29-35

  Lübbert, Christoph ^a,b,d   Opitz, Bernhard M ^b   Harms Zwingenberger, Gundel ^c   Nietsch, Hubertus H ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Krankenhaus St Elisabeth und St Barbara   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Mediterranean area; Pancytopenia; Splenomegaly; Travel history; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CYTOLOGY; FEVER; HUMAN; HUMAN CELL; PANCYTOPENIA; POLYMERASE CHAIN REACTION; SEROLOGY; SPAIN; SPLENOMEGALY; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; DIAGNOSIS, DIFFERENTIAL; FEVER; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIPOSOMES; MALE; MEDITERRANEAN ISLANDS; PANCYTOPENIA; POLYMERASE CHAIN REACTION; SPAIN; SPLENOMEGALY; TRAVEL; TREATMENT OUTCOME;

LEISHMANIA INFANTUM;

EID: 38849104501     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-008-1003-5     Document Type: Article

References (32)

1. AWMF-Leitlinie 042-004 (2/2006). Diagnostik und Therapie der viszeralen Leishmaniasis (Kala-Azar). Düsseldorf: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, 2006 (http://www. leitlinien.net).
2. Basset D, Faraut F, Marty P, et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 2005;7:1370-5.
3. Bhattacharya SK, Jha TK, Sundar S, et al. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 2004;38:217-21.
4. Bhattacharya SK, Sinha PK, Sundar S, et al. Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis 2007;196:591-8.
5. Blum J, Hatz C. Tropen- und Reisemedizin: Leishmaniose - Neues zu einer alten Krankheit. Schweiz Med Forum 2006;6:36-7.
6. Bogdan C, Schönian G, Banuls AL, et al. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin Infect Dis 2001;32:302-6.
7. Cruz I, Chicarro C, Nieto J, et al. Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol 2005;44:2343-7.
8. Dantas-Torres F. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania infantum and Leishmania braziliensis. Vet Parasitol 2007;149:139-46.
9. Davidson RN, Di Martino L, Gradoni L, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994;87:75-81.
10. Depaquit J, Naucke TJ, Schmitt C. A molecular analysis of the subgenus Transphlebotomus Artemiev, 1984 (Phlebotomus, Diptera, Psychodidae) inferred from ND4 mtDNA with new northern records of Phlebotomus mascittii Grassi, 1908. Parasitol Res 2005;95:113-6.
11. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in europe. Ann Trop Med Parasitol 2003;97:3-15.
12. Gothe R, Nolte I, Kraft W. Leishmaniasis in dogs in Germany: epidemiological case analysis and alternatives to conventional causal therapy. Tierärztl Prax 1997;25:68-73.
13. Gramiccia M, Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol 2005;35:1169-80.
14. Hagenah GC, Wündisch T, Eckstein E. et al. Sepsisähnliches Krankheitsbild bei Immunsuppression nach früherem Mallorca-Urlaub. Internist (Berl) 2007;48:727-30.
15. Harms-Zwingenberger G, Bienzle U. Nach Deutschland importierte Leishmaniosen. Dtsch Ärztebl 2007;104:A3108-13.
16. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
17. Hoffmann-Tonn K, Geis S, Peckelsen C, et al. Akute fieberhafte Erkrankung mit Spenomegalie und Panzytopenie. Internist (Berl) 2007;48:731-6.
18. Lengg N, Eigenmann F, Wodzynski A, et al. Eine aussergewöhnliche Ursache von hohem Fieber mit progredienter Panzytopenie. Schweiz Med Forum 2006;6:1111-3.
19. Mazloumi Gavgani AS, Hodjati MH, et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002;360:374-9.
20. Mishra J, Saxena A, Singh S. Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 2007;14:1153-69.
21. Murray HW, Berman JD, Davies JR, et al. Advances in leishmaniasis. Lancet 2005;366:1561-77.
22. Naucke TJ, Pesson B. Presence of Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 (Diptera: Psychodidae) in Germany. Parasitol Res 2000;86:335-6.
23. Naucke TJ, Schmitt C. Is leishmaniasis becoming endemic in Germany? Int J Med Microbiol Infect Dis 2003;47:349-58.
24. Pollakis E, Herren T. Viszerale Leishmaniose mit Panzytopenie und Splenomegalie (Kala-Azar). Schweiz Med Forum 2001;1:174-5.
25. Schönian G, Nasereddin A, Dinse N, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003;47:349-58.
26. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 2004;10:307-15.
27. Soto J, Soto P. Oral miltefosine to treat leishmaniasis. Biomedica 2006;26:207-17.
28. Sudeck H. Kala-Azar: seltener Import und wichtige Differentialdiagnose. Internist 2006;47:825-34.
29. Sundar S, Mehta H, Suresh A, et al. Amphotericin B treatment for Indian visceral leishmanisis: conventional versus lipid formulation. Clin Infect Dis 2004;38:377-83.
30. Weisser M, Khanlari B, Terracciano L, et al. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas? Clin Microbiol Infect 2007;13:751-3.
31. Weitzel T, Mühlberger N, Jelinek T, et al. Imported leishmaniasis in Germany 2001-2004: data of the SIMPID Surveillance Network. Eur J Clin Microbiol Infect Dis 2005;24:471-6.
32. WHO. Leishmaniasis - fact sheet. Geneva: World Health Organization, 2007 (http://www.who.int).